Role of aldehyde dehydrogenase in hypoxic vasodilator effects of nitrite in rats and humans

British Journal of Pharmacology
Sayqa ArifM Madhani

Abstract

Hypoxic conditions favour the reduction of nitrite to nitric oxide (NO) to elicit vasodilatation, but the mechanism(s) responsible for bioconversion remains ill defined. In the present study, we assess the role of aldehyde dehydrogenase 2 (ALDH2) in nitrite bioactivation under normoxia and hypoxia in the rat and human vasculature. The role of ALDH2 in vascular responses to nitrite was studied using rat thoracic aorta and gluteal subcutaneous fat resistance vessels from patients with heart failure (HF; 16 patients) in vitro and by measurement of changes in forearm blood flow (FBF) during intra-arterial nitrite infusion (21 patients) in vivo. Specifically, we investigated the effects of (i) ALDH2 inhibition by cyanamide or propionaldehyde and the (ii) tolerance-independent inactivation of ALDH2 by glyceryl trinitrate (GTN) on the vasodilator activity of nitrite. In each setting, nitrite effects were measured via evaluation of the concentration-response relationship under normoxic and hypoxic conditions in the absence or presence of ALDH2 inhibitors. Both in rat aorta and human resistance vessels, dilatation to nitrite was diminished following ALDH2 inhibition, in particular under hypoxia. In humans there was a non-significant tre...Continue Reading

References

Jan 1, 1992·Acta Psychiatrica Scandinavica. Supplementum·B Johansson
Oct 12, 2000·Proceedings of the National Academy of Sciences of the United States of America·M T GladwinR O Cannon
Jun 6, 2002·Proceedings of the National Academy of Sciences of the United States of America·Zhiqiang ChenJonathan S Stamler
Oct 24, 2003·Molecular Pharmacology·Jon DiFabioBrian M Bennett
Nov 5, 2003·Nature Medicine·Kenyatta CosbyMark T Gladwin
May 25, 2004·Primary Care Companion to the Journal of Clinical Psychiatry·Jeff C. Huffman, Theodore A. Stern
Jul 30, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Isla S MackenzieIan B Wilkinson
May 24, 2006·Proceedings of the National Academy of Sciences of the United States of America·Michael AngeloJonathan S Stamler
Dec 29, 2006·The New England Journal of Medicine·Filip J LarsenEddie Weitzberg
Feb 21, 2007·Hypertension·Jennifer C IrvineBarbara K Kemp-Harper
Nov 6, 2007·Nature Chemical Biology·Swati BasuDaniel B Kim-Shapiro
Jan 24, 2008·Circulation·Abdul R MaherMichael P Frenneaux
Feb 15, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Martin W HuellnerThomas Rau
Dec 24, 2009·Canadian Journal of Physiology and Pharmacology·Neel H GolwalaPhilip J Kadowitz
Jun 15, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Adeleke M BadejoPhilip J Kadowitz
Oct 5, 2010·Cardiovascular Research·Julian O M OrmerodMichael P Frenneaux
Oct 13, 2010·Cardiovascular Research·Jon O LundbergEddie Weitzberg
Feb 8, 2011·The Journal of Biological Chemistry·Mauro TisoMark T Gladwin
Sep 25, 2012·Journal of the American College of Cardiology·Catherine N MartiJaved Butler
Mar 12, 2013·British Journal of Pharmacology·Abdul R MaherMichael P Frenneaux
Nov 16, 2013·Nucleic Acids Research·Adam J PawsonUNKNOWN NC-IUPHAR
Feb 13, 2014·British Journal of Pharmacology·Stephen P H AlexanderUNKNOWN CGTP Collaborators
Feb 18, 2014·British Journal of Pharmacology·Stephen P H AlexanderUNKNOWN CGTP Collaborators
Jul 6, 2014·Pharmacology & Therapeutics·J C BaileyM Madhani

❮ Previous
Next ❯

Citations

Apr 7, 2015·Free Radical Biology & Medicine·Ming LiuMattias Carlström
Feb 3, 2016·Nihon eiseigaku zasshi. Japanese journal of hygiene·Akiko Matsumoto
Jul 14, 2018·Clinical and Experimental Pharmacology & Physiology·Katie AllenDavid Hauton
Jul 25, 2018·World Journal of Gastroenterology : WJG·Arnau Panisello-RosellóJoan Roselló-Catafau

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
biopsies

Software Mentioned

Prism
GraphPad

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.